Other Species / Isoforms
  SFRS3 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S5-p
___MHRDsCPLDCkV
0 26
SFRS3 (human) ___MHRDsCPLDCkV S5-p
SFRS3 (mouse) ___MHRDsCPLDCkV S5-p
SFRS3 (rat) ___MHRDSCPLDCKV S5
K11
DsCPLDCKVYVGNLG
0 2
SFRS3 (human) DsCPLDCkVyVGNLG K11-ac
SFRS3 (mouse) DsCPLDCKVYVGNLG K11
SFRS3 (rat) DSCPLDCKVYVGNLG K11
K11-ub
DsCPLDCkVYVGNLG
0 3
SFRS3 (human) DsCPLDCkVyVGNLG K11-ub
SFRS3 (mouse) DsCPLDCkVYVGNLG K11-ub
SFRS3 (rat) DSCPLDCKVYVGNLG K11
Y13
CPLDCkVYVGNLGNN
0 6
SFRS3 (human) CPLDCkVyVGNLGNN Y13-p
SFRS3 (mouse) CPLDCkVYVGNLGNN Y13
SFRS3 (rat) CPLDCKVYVGNLGNN Y13
K23
NLGNNGNKTELERAF
0 4
SFRS3 (human) NLGNNGNktELErAF K23-ac
SFRS3 (mouse) NLGNNGNKTELERAF K23
SFRS3 (rat) NLGNNGNkTELERAF K23-ac
K23-ub
NLGNNGNkTELERAF
0 38
SFRS3 (human) NLGNNGNktELErAF K23-ub
SFRS3 (mouse) NLGNNGNkTELERAF K23-ub
SFRS3 (rat) NLGNNGNKTELERAF K23
T24
LGNNGNkTELERAFG
0 1
SFRS3 (human) LGNNGNktELErAFG T24-p
SFRS3 (mouse) LGNNGNkTELERAFG T24
SFRS3 (rat) LGNNGNkTELERAFG T24
R28
GNkTELERAFGyYGP
0 1
SFRS3 (human) GNktELErAFGyyGP R28-m1
SFRS3 (mouse) GNkTELERAFGyYGP R28
SFRS3 (rat) GNkTELERAFGYYGP R28
Y32-p
ELERAFGyYGPLRSV
Upstream
0 171
Regulatory protein:
  • Src (mouse)
SFRS3 (human) ELErAFGyyGPLrSV Y32-p
SFRS3 (mouse) ELERAFGyYGPLRSV Y32-p
SFRS3 (rat) ELERAFGYYGPLRSV Y32
Y33
LERAFGyYGPLRSVW
0 7
SFRS3 (human) LErAFGyyGPLrSVW Y33-p
SFRS3 (mouse) LERAFGyYGPLRSVW Y33
SFRS3 (rat) LERAFGYYGPLRSVW Y33
R37
FGyYGPLRSVWVARN
0 1
SFRS3 (human) FGyyGPLrSVWVARN R37-m1
SFRS3 (mouse) FGyYGPLRSVWVARN R37
SFRS3 (rat) FGYYGPLRSVWVARN R37
R57
FVEFEDPRDAADAVR
0 1
SFRS3 (human) FVEFEDPrDAADAVR R57-m1
SFRS3 (mouse) FVEFEDPRDAADAVR R57
SFRS3 (rat) FVEFEDPRDAADAVR R57
T70
VRELDGRTLCGCRVR
0 20
SFRS3 (human) VRELDGRtLCGCRVR T70-p
SFRS3 (mouse) VRELDGRTLCGCRVR T70
SFRS3 (rat) VRELDGRTLCGCRVR T70
S81
CRVRVELSNGEkRsR
0 5
SFRS3 (human) CRVRVELsNGEkRSR S81-p
SFRS3 (mouse) CRVRVELSNGEkRsR S81
SFRS3 (rat) CRVRVELSNGEkRSR S81
K85
VELSNGEKRsRNRGP
0 4
SFRS3 (human) VELsNGEkRSRNrGP K85-ac
SFRS3 (mouse) VELSNGEKRsRNRGP K85
SFRS3 (rat) VELSNGEkRSRNRGP K85-ac
K85-ub
VELSNGEkRsRNRGP
0 49
SFRS3 (human) VELsNGEkRSRNrGP K85-ub
SFRS3 (mouse) VELSNGEkRsRNRGP K85-ub
SFRS3 (rat) VELSNGEKRSRNRGP K85
K85
VELSNGEKRsRNRGP
0 1
SFRS3 (human) VELsNGEkRSRNrGP K85-sm
SFRS3 (mouse) VELSNGEKRsRNRGP K85
SFRS3 (rat) VELSNGEKRSRNRGP K85
S87-p
LSNGEkRsRNRGPPP
0 1
SFRS3 (human) LsNGEkRSRNrGPPP S87
SFRS3 (mouse) LSNGEkRsRNRGPPP S87-p
SFRS3 (rat) LSNGEkRSRNRGPPP S87
R90
GEkRsRNRGPPPsWG
0 1
SFRS3 (human) GEkRSRNrGPPPsWG R90-m1
SFRS3 (mouse) GEkRsRNRGPPPsWG R90
SFRS3 (rat) GEkRSRNRGPPPSWG R90
S95-p
RNRGPPPsWGRRPRD
0 10
SFRS3 (human) RNrGPPPsWGrRPRD S95-p
SFRS3 (mouse) RNRGPPPsWGRRPRD S95-p
SFRS3 (rat) RNRGPPPSWGRRPRD S95
R98
GPPPsWGRRPRDDYR
0 2
SFRS3 (human) GPPPsWGrRPRDDYR R98-m1
SFRS3 (mouse) GPPPsWGRRPRDDYR R98
SFRS3 (rat) GPPPSWGRRPRDDYR R98
S108-p
RDDYRRRsPPPRRRS
Upstream
0 53
Treatment
  • LPA
SFRS3 (human) RDDYRRRsPPPRRRS S108-p
SFRS3 (mouse) RDDYRRRsPPPRRRS S108-p
SFRS3 (rat) RDDYRRRsPPPRRRS S108-p
S120-p
RRSPRRRsFsRsRsR
Upstream
0 4
Treatment
  • NAG-thiazoline
  • okadaic_acid
  • PUGNAc
SFRS3 (human) RRSPRRRsFsRsRsR S120-p
SFRS3 (mouse) RRSPRRRsFsRsRsR S120-p
SFRS3 (rat) RRSPRRRSFSRSRsR S120
S122-p
SPRRRsFsRsRsRsL
1 4
SFRS3 (human) SPRRRsFsRsRsRsL S122-p
SFRS3 (mouse) SPRRRsFsRsRsRsL S122-p
SFRS3 (rat) SPRRRSFSRSRsRsL S122
S124-p
RRRsFsRsRsRsLsR
Upstream
0 5
Treatment
  • NAG-thiazoline
  • okadaic_acid
  • PUGNAc
SFRS3 (human) RRRsFsRsRsRsLsR S124-p
SFRS3 (mouse) RRRsFsRsRsRsLsR S124-p
SFRS3 (rat) RRRSFSRSRsRsLsR S124
S126-p
RsFsRsRsRsLsRDR
0 9
SFRS3 (human) RsFsRsRsRsLsRDR S126-p
SFRS3 (mouse) RsFsRsRsRsLsRDR S126-p
SFRS3 (rat) RSFSRSRsRsLsRDR S126-p
S128-p
FsRsRsRsLsRDRRR
1 10
SFRS3 (human) FsRsRsRsLsRDRRR S128-p
SFRS3 (mouse) FsRsRsRsLsRDRRR S128-p
SFRS3 (rat) FSRSRsRsLsRDRRR S128-p
S130-p
RsRsRsLsRDRRRER
1 9
SFRS3 (human) RsRsRsLsRDRRRER S130-p
SFRS3 (mouse) RsRsRsLsRDRRRER S130-p
SFRS3 (rat) RSRsRsLsRDRRRER S130-p
S138-p
RDRRRERsLsRERNH
1 23
SFRS3 (human) RDRRRERsLsRERNH S138-p
SFRS3 (mouse) RDRRRERsLsRERNH S138-p
SFRS3 (rat) RDRRRERSLsRERNH S138
S140-p
RRRERsLsRERNHKP
1 24
SFRS3 (human) RRRERsLsRERNHKP S140-p
SFRS3 (mouse) RRRERsLsRERNHKP S140-p
SFRS3 (rat) RRRERSLsRERNHKP S140-p
S148-p
RERNHKPsRsFsRsR
0 26
SFRS3 (human) RERNHKPsRsFsRsR S148-p
SFRS3 (mouse) RERNHKPsRsFsRsR S148-p
SFRS3 (rat) RERNHKPsRsFsRSR S148-p
S150-p
RNHKPsRsFsRsRSR
Upstream
0 25
Treatment
  • NAG-thiazoline
  • okadaic_acid
  • PUGNAc
SFRS3 (human) RNHKPsRsFsRsRSR S150-p
SFRS3 (mouse) RNHKPsRsFsRsRSR S150-p
SFRS3 (rat) RNHKPsRsFsRSRSR S150-p
S152-p
HKPsRsFsRsRSRSR
0 23
SFRS3 (human) HKPsRsFsRsRSRSR S152-p
SFRS3 (mouse) HKPsRsFsRsRSRSR S152-p
SFRS3 (rat) HKPsRsFsRSRSRSR S152-p
S154-p
PsRsFsRsRSRSRSN
Upstream
0 5
Treatment
  • NAG-thiazoline
  • okadaic_acid
  • PUGNAc
SFRS3 (human) PsRsFsRsRSRSRSN S154-p
SFRS3 (mouse) PsRsFsRsRSRSRSN S154-p
SFRS3 (rat) PsRsFsRSRSRSRSN S154